Stocks
ANI Pharmaceuticals (ANIP) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 2.03 | 6.22 | 12.7 | 7.47 | 0.86 | 0.60 | |||
| Changes by years, y/y, % | -1% | +207% | +104% | -41% | -88% | -15.9% | |||
ANI Pharmaceuticals. Debt/EBITDA
ANI Pharmaceuticals. Debt/EBITDA, changes, %
ANI Pharmaceuticals (ANIP) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| Debt/EBITDA | 1.40 | 0.89 | 0.86 | 0.64 | 0.60 | 0.60 | ||
| Changes by years, y/y, % | -128% | -114% | -88% | -81% | -57% | |||
| Changes by quarters, q/q, % | -59% | -37% | -3% | -26% | -6% | |||
